Abiopharma

🔍 Boenisch Sandra (Executive)

Company: ANAVEX LIFE SCIENCES CORP. (AVXL)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Acquired 12,500 shares of Stock Option (Right to Buy) at $8.58 per share (Derivative)
  Date: 2026-01-06 | Code: A | Expires: 2035-03-31 | Exercise: 2026-01-06 | equity_swap_involved: 0 | shares_owned_after: 12,500.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: On March 31, 2025, the reporting person was granted an option to purchase 50,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which was a second regulatory dialogue for blarcamesine. The performance criteria for this milestone was met, resulting in vesting of the option as to 12,500 shares.